Balchem (NASDAQ:BCPC) was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued on Thursday.
Balchem (NASDAQ BCPC) traded down $0.20 on Thursday, reaching $84.53. 87,979 shares of the company were exchanged, compared to its average volume of 94,556. The firm has a market cap of $2,711.72, a P/E ratio of 33.49 and a beta of 1.09. Balchem has a 12-month low of $71.95 and a 12-month high of $89.50. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.49 and a current ratio of 2.16.
Balchem (NASDAQ:BCPC) last posted its earnings results on Tuesday, November 7th. The basic materials company reported $0.63 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.62 by $0.01. The firm had revenue of $150.72 million during the quarter. Balchem had a net margin of 11.11% and a return on equity of 14.68%.
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. increased its position in Balchem by 1.4% during the 2nd quarter. Vanguard Group Inc. now owns 2,885,217 shares of the basic materials company’s stock worth $224,210,000 after purchasing an additional 40,016 shares in the last quarter. Wasatch Advisors Inc. increased its position in Balchem by 4.6% during the 2nd quarter. Wasatch Advisors Inc. now owns 1,153,188 shares of the basic materials company’s stock worth $89,614,000 after purchasing an additional 50,841 shares in the last quarter. State Street Corp increased its position in Balchem by 5.2% during the 2nd quarter. State Street Corp now owns 780,131 shares of the basic materials company’s stock worth $60,619,000 after purchasing an additional 38,522 shares in the last quarter. Dimensional Fund Advisors LP increased its position in Balchem by 0.5% during the 3rd quarter. Dimensional Fund Advisors LP now owns 727,055 shares of the basic materials company’s stock worth $59,103,000 after purchasing an additional 3,551 shares in the last quarter. Finally, Conestoga Capital Advisors LLC increased its position in Balchem by 49.1% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 533,894 shares of the basic materials company’s stock worth $43,400,000 after purchasing an additional 175,850 shares in the last quarter. 87.20% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: This piece of content was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of United States and international copyright legislation. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2017/12/08/balchem-bcpc-downgraded-by-bidaskclub-to-sell.html.
Balchem Company Profile
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.
Receive News & Ratings for Balchem Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem Corporation and related companies with MarketBeat.com's FREE daily email newsletter.